Total Payments
$828,071
2024 Payments
$125,310
Companies
26
Transactions
602
Payment Breakdown by Category
Other$531,619 (64.2%)
Consulting$183,354 (22.1%)
Travel$97,404 (11.8%)
Food & Beverage$11,278 (1.4%)
Research$4,216 (0.5%)
Education$200.20 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $494,609 | 167 | 59.7% |
| Consulting Fee | $183,354 | 30 | 22.1% |
| Travel and Lodging | $97,404 | 222 | 11.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $29,410 | 7 | 3.6% |
| Food and Beverage | $11,278 | 165 | 1.4% |
| Honoraria | $7,600 | 4 | 0.9% |
| Unspecified | $4,216 | 4 | 0.5% |
| Education | $200.20 | 3 | 0.0% |
Payments by Type
General
$823,855
598 transactions
Research
$4,216
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $195,990 | 135 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $157,964 | 146 | $0 (2024) |
| United Therapeutics Corporation | $140,351 | 21 | $0 (2024) |
| BIOVERATIV THERAPEUTICS INC. | $139,200 | 93 | $0 (2021) |
| Amgen Inc. | $111,129 | 117 | $0 (2024) |
| SERVIER PHARMACEUTICALS LLC | $37,876 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $26,019 | 7 | $0 (2021) |
| Octapharma USA, Inc. | $16,910 | 13 | $0 (2022) |
| Alkermes, Inc. | $1,900 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $108.07 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125,310 | 91 | JAZZ PHARMACEUTICALS INC. ($42,866) |
| 2023 | $241,237 | 106 | United Therapeutics Corporation ($110,525) |
| 2022 | $86,934 | 79 | GENZYME CORPORATION ($51,032) |
| 2021 | $54,820 | 45 | Amgen Inc. ($30,625) |
| 2020 | $49,437 | 46 | Amgen Inc. ($34,368) |
| 2019 | $116,133 | 93 | BIOVERATIV THERAPEUTICS INC. ($60,116) |
| 2018 | $79,066 | 75 | Jazz Pharmaceuticals Inc. ($37,959) |
| 2017 | $75,134 | 67 | Bioverativ Therapeutics Inc. ($43,440) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $217.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $693.75 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,580.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $221.62 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $102.29 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/17/2024 | Novo Nordisk Inc | Esperoct (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Hemophilia | ||||||
| 12/14/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $560.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,580.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,790.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $331.67 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $307.59 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $148.66 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $146.20 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $44.82 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/26/2024 | United Therapeutics Corporation | — | Consulting Fee | Cash or cash equivalent | $4,860.00 | General |
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $142.36 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/17/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $1.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/12/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $391.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/05/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $542.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Travel and Lodging | In-kind items and services | $552.45 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/30/2024 | SOBI, INC | GAMIFANT (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: HEMATOLOGY | ||||||
| 10/25/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,163.00 | General |
| Category: Hematology | ||||||
| 10/05/2024 | GENZYME CORPORATION | ALTUVIIIO (Biological) | Consulting Fee | Cash or cash equivalent | $8,338.00 | General |
| Category: Hematology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GENA-05 | Octapharma USA, Inc. | $4,216 | 4 |
About Dr. Guillermo De Angulo, MD
Dr. Guillermo De Angulo, MD is a Pediatric Hematology-Oncology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679791370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guillermo De Angulo, MD has received a total of $828,071 in payments from pharmaceutical and medical device companies, with $125,310 received in 2024. These payments were reported across 602 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($494,609).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Other Specialties Pediatric Hematology-Oncology
- Location Miami, FL
- Active Since 04/20/2007
- Last Updated 04/30/2013
- Taxonomy Code 2080P0207X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679791370
Products in Payments
- Blincyto (Biological) $110,173
- RYLAZE (Drug) $88,631
- ALTUVIIIO (Biological) $76,319
- ELOCTATE (Drug) $64,289
- Erwinaze (Drug) $62,674
- ELOCTATE (Biological) $34,943
- Eloctate (Drug) $26,411
- ALPROLIX (Biological) $25,671
- NO PRODUCT DISCUSSED (Drug) $25,301
- ALPROLIX (Drug) $21,489
- ASPARLAS (Drug) $19,802
- Asparlas (Drug) $13,963
- NUWIQ (Biological) $13,673
- ELITEK (Drug) $8,047
- Alprolix (Drug) $3,874
- FIBRYGA (Biological) $2,621
- CABLIVI (Biological) $2,437
- ONCASPAR (Drug) $2,040
- Tibsovo (Drug) $850.00
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) $600.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Miami
Dr. Joanna Davis, Md, MD
Pediatric Hematology-Oncology — Payments: $563,888
Pediatric Hematology-Oncology $563,888
Rachel Kronenfeld, Md, MD
Pediatric Hematology-Oncology — Payments: $40,150
Pediatric Hematology-Oncology $40,150
Julio Barredo, Md, MD
Pediatric Hematology-Oncology — Payments: $19,170
Pediatric Hematology-Oncology $19,170
Dr. Ofelia Alvarez, Md, MD
Pediatric Hematology-Oncology — Payments: $8,660
Pediatric Hematology-Oncology $8,660
Maggie Fader, Md, MD
Pediatric Hematology-Oncology — Payments: $5,694
Pediatric Hematology-Oncology $5,694
Dr. Athena Pefkarou, Md, MD
Pediatric Hematology-Oncology — Payments: $2,397
Pediatric Hematology-Oncology $2,397